4.6 Article

Evidence That Onset of Clinical Psychosis Is an Outcome of Progressively More Persistent Subclinical Psychotic Experiences: An 8-Year Cohort Study

期刊

SCHIZOPHRENIA BULLETIN
卷 37, 期 1, 页码 84-93

出版社

OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbp022

关键词

epidemiology; general population; psychosis onset; adolescence; transition to clinical relevance; subclinical psychosis

资金

  1. German Federal Ministry of Education and Research (BMBF) [01EB9405/6, 01EB9910/6, EB10106200, 01EB0140, 01EB0440]
  2. Deutsche Forschungsgemeinschaft (DFG) [LA1148/1-1, WI2246/7-1, WI709/8-1]
  3. European Community [MEST-CT-2005-020589]
  4. Dutch Medical Council [916.76.147]
  5. Wyeth
  6. Eli Lilly and Company
  7. Novartis
  8. Pfizer
  9. Schering-Plough
  10. GSK
  11. Organon
  12. BMS
  13. AstraZeneca

向作者/读者索取更多资源

This study examined the hypothesis that developmental expression of psychometric risk in the form of subclinical psychotic experiences in the general population is usually transitory but in some instances may become abnormally persistent and progress to a clinical psychotic state. A prospective cohort study was conducted in a general population sample of 845 adolescents, aged 14-17 years, in Munich, Germany (Early Developmental Stages of Psychopathology Study). Expression of psychosis was assessed 4 times (T0-T3) over a period of 8.4 years. Transition from subclinical psychosis at T0-T2 to clinical psychosis in terms of impairment at T3 was examined as a function of the level of prior persistence of subclinical psychosis (present never, once, twice, or thrice). The more the subclinical psychosis persisted over the period T0-T2, the greater the risk of transition to clinical psychosis at T3 in a dose-response fashion (subclinical psychosis expression once over T0-T2: odds ratio [OR] = 1.5 [95% confidence interval {CI} = 0.6-3.7], posttest probability [PP] = 5%; twice: OR = 5.0 [95% CI = 1.6-15.9], PP = 16%; at all 3 measurements: OR = 9.9 [95% CI = 2.5-39.8], PP = 27%). Of all clinical psychosis at T3, more than a third (38.3%) was preceded by subclinical psychotic experiences at least once and a fifth (19.6%) at least twice. Consequently, a significant proportion of psychotic disorder may be conceptualized as the rare poor outcome of a common developmental phenotype characterized by persistence of psychometrically detectable subclinical psychotic experiences. This may be summarized descriptively as a psychosis proneness-persistence-impairment model of psychotic disorder.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据